Results 261 to 270 of about 59,427 (290)
Some of the next articles are maybe not open access.

The Association Between Human Leukocyte Antigens and ITP, TTP, and HIT

Journal of pediatric hematology/oncology, 2019
Background: Autoimmune thrombocytopenia in immune thrombocytopenic purpura (ITP), thrombotic thrombocytopenic purpura (TTP), and heparin-induced thrombocytopenia (HIT) is associated with immunologic degradation of platelets and reduced platelet counts in
Ali Amin Asnafi   +4 more
semanticscholar   +1 more source

A comparison of LIN and TTP/A [PDF]

open access: possible2000 IEEE International Workshop on Factory Communication Systems. Proceedings (Cat. No.00TH8531), 2002
The paper compares two novel field-bus protocols for low-cost single-chip smart sensor and actuator nodes, LIN and TTP/A. Both protocols are central-master UART protocols, where the master with its precise oscillator establishes the stable time-base required by the slaves to synchronize their imprecise on-chip oscillators.
Hermann Kopetz   +2 more
openaire   +1 more source

Ofatumumab for TTP in a Patient with Anaphylaxis Associated with Rituximab.

New England Journal of Medicine, 2018
Ofatumumab in Rituximab-Allergic TTP A patient with refractory thrombotic thrombocytopenic purpura had anaphylaxis associated with rituximab that was mediated by human antichimeric antibodies.
Maeve P. Crowley, V. Mcdonald, M. Scully
semanticscholar   +1 more source

Crystal Structures of TMEO-TTP and (TMEO-TTP)[AuBr2]·THF

Bulletin of the Chemical Society of Japan, 1994
Abstract The molecular and crystal structures of the title compounds, where TMEO-TTP is 2-[4,5-bis(methylthio)1,3-dithiol-2-ylidene]-5-[4,5-ethylenedioxy-1,3-dithiol-2-ylidene]-1,3,4,6-tetrathiapentalene, have been investigated by X-ray crystal structure analysis.
Yohji Misaki   +4 more
openaire   +2 more sources

Race, rituximab, and relapse in TTP

Blood, 2022
Abstract Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is characterized by recurring episodes of thrombotic microangiopathy, causing ischemic organ impairment. Black patients are overrepresented in iTTP cohorts in the United States, but racial disparities in iTTP outcome and response to therapy have not been studied.
Shruti Chaturvedi   +28 more
openaire   +2 more sources

Von Willebrand Factor--A New Target for TTP Treatment?

New England Journal of Medicine, 2016
Thrombotic thrombocytopenic purpura (TTP), a rare thrombotic microangiopathy, is defined by a mechanical hemolytic anemia, severe thrombocytopenia, and visceral ischemia due to systemic platelet-rich microthrombi.
A. Veyradier
semanticscholar   +1 more source

TTP and pregnancy

British Journal of Haematology
SummaryAcute thrombocytopenic purpura (TTP) may present at any stage of pregnancy and the puerperium. Without prompt diagnosis and therapy, serious maternal and fetal outcomes may result. ADAMTS13 replacement via plasma exchange and immunosuppression are the mainstay of treatment.
P. Gounder, M. Scully
openaire   +2 more sources

Acquired Coagulation Disorders and TTP [PDF]

open access: possible, 2007
The most common causes of acquired clotting factor deficiencies associated with bleeding are decreased or abnormal synthesis of clotting factors caused by liver disease or disseminated intravascular coagulation (DIC). The latter is seen in many severe illnesses, including metastatic cancer and infectious diseases. Vitamin K deficiency is another common
George M. Rodgers, George M. Rodgers
openaire   +1 more source

Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.

Blood, 2014
Atypical hemolytic uremic syndrome (aHUS) is characterized by dysregulated complement activity, the development of a thrombotic microangiopathy (TMA), and widespread end organ injury. aHUS remains a clinical diagnosis without an objective laboratory test
S. Cataland   +4 more
semanticscholar   +1 more source

Should TTPs be licensed?

Information Security Technical Report, 1997
Abstract Cryptography has a very important role to play in providing security for modern corporate networks. There are, however, complex legal and governmental restrictions which currently limit the use of strong controls based on cryptographic methods.
openaire   +2 more sources

Home - About - Disclaimer - Privacy